Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity

AIMS: The CHHiP (Conventional or Hypofractionated High-dose Intensity Modulated Radiotherapy In Prostate Cancer; CRUK/06/016) trial investigated hypofractionated radiotherapy for localised prostate cancer. Forward- (FP) or inverse-planned (IP) intensity-modulated techniques were permitted. Dose–volu...

Descripción completa

Detalles Bibliográficos
Autores principales: Naismith, O.F., Griffin, C., Syndikus, I., South, C., Mayles, H., Mayles, P., Khoo, V., Scrase, C., Graham, J., Hassan, S., Hall, E., Dearnaley, D.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688097/
https://www.ncbi.nlm.nih.gov/pubmed/31178346
http://dx.doi.org/10.1016/j.clon.2019.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688097/
https://www.ncbi.nlm.nih.gov/pubmed/31178346
http://dx.doi.org/10.1016/j.clon.2019.05.002

Ejemplares similares